Zomedica Corp. Operating Lease, Right-of-Use Asset, Amortization Expense
Zomedica Corp. (ZOMDF) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $187.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2025-03-13
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for the quarter ending 2020-03-31 was $42.45K, a 66.67% decline year-over-year.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $187.00K, a 1068.75% increase from fiscal 2022.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $16.00K.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for fiscal 2020 was $42.45K, a 91.67% decline from fiscal 2019.
- Zomedica Corp. operating lease, right-of-use asset, amortization expense for fiscal 2019 was $509.38K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $187.00K 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $16.00K 10-K · filed 2024-04-01 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 derived: sum of 3 quarters · filed 2021-02-26 | $42.45K 10-K · filed 2021-02-26 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $42.45K 10-Q · filed 2020-11-12 | $169.79K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $42.45K 10-Q · filed 2020-08-10 | $169.79K derived: sum of 3 quarters · filed 2021-05-12 | $297.14K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $42.45K 10-Q · filed 2021-05-12 | $169.79K derived: sum of 2 quarters · filed 2021-05-12 | $297.14K derived: sum of 3 quarters · filed 2021-05-12 | $424.48K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $127.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $254.69K derived: sum of 2 quarters · filed 2021-02-26 | $382.04K derived: sum of 3 quarters · filed 2021-02-26 | $509.38K 10-K · filed 2021-02-26 |
| 2019-09-30 | $127.34K 10-Q · filed 2020-11-12 | $254.69K derived: sum of 2 quarters · filed 2020-11-12 | $382.04K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $127.34K 10-Q · filed 2020-08-10 | $254.69K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $127.34K 10-Q · filed 2020-05-11 |